1. Bevacizumab versus ranibizumab: why are we not playing the joker?

   • Roberto Banfi
   • Francesco Attanasio
   • Gianni Virgili

   Commentary 28 April 2013 Pages: 507 - 509

2. A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment

   • Pablo Moura Santos
   • Lúcia Noblat
   • Álvaro A. Cruz

   Commentary 23 June 2013 Pages: 510 - 512

3. Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma: what is the evidence?

   • Vanessa Hegele
   • Paula Stoll
   • Luciane Pereira Lindenmeyer

   Review Article 05 June 2013 Pages: 513 - 519

4. Community pharmacy practice in China: past, present and future

   • Yu Fang
   • Shimin Yang
   • Jun Liu

   Review Article 10 May 2013 Pages: 520 - 528

   

5. Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there?

   • Yuefeng Rao
   • Feiyue Zheng

   Case Report 27 April 2013 Pages: 529 - 531

   

6. Eosinophilia associated with bupropion

   • Montserrat García
   • Borja Ruiz
   • Unax Lertxundi

   Case Report 12 June 2013 Pages: 532 - 534

7. Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism

   • Yat-fung Shea
   • Ming-yee Maggie Mok
   • Leung-wing Chu

   Case Report 26 June 2013 Pages: 535 - 537

8. Filgrastim therapy in a child with neutropenia induced by linezolid

   • Marta Hernández Segurado
   • Maria Ángeles Arias Moya
   • María Isabel Panadero Esteban

   Case Report Open access 03 July 2013 Pages: 538 - 541

   

9. Exploring health professionals’ experiences of medication errors in Saudi Arabia

   • Mansour Tobaiqy
   • Derek Stewart

   Short Research Report 07 May 2013 Pages: 542 - 545

   

10. Inadequate management of medicines by the older-aged living in a retirement village

    • Sheila A. Doggrell

    Short Research Report 09 May 2013 Pages: 546 - 549

11. Use of monoclonal antibodies for metastatic colorectal cancer in the andalusian public health system

    • Bernardo Santos-Ramos
    • Rocío Fernández-Fernández
    • Javier Bautista-Paloma

    Short Research Report 15 May 2013 Pages: 550 - 553

    

12. Medication surveillance on intravenous cytotoxic agents: a retrospective study

    • Brigit van Oijen
    • Rob Janknegt
    • Hugo van der Kuy

    Research Article 14 April 2013 Pages: 554 - 559

13. Online drug databases: a new method to assess and compare inclusion of clinically relevant information

    • Cristina Silva
    • Paula Fresco
    • Ana Cristina Ribeiro Rama

    Research Article 02 June 2013 Pages: 560 - 569

    

14. Mandatory continuing professional education in pharmacy: the Singapore experience

    • Hui-Gek Ang
    • Yong-Hao Pua
    • Nur Azah Subari

    Research Article 04 April 2013 Pages: 570 - 576

15. Potential medication errors associated with computer prescriber order entry

    • Elena Villamañán
    • Yolanda Larrubia
    • Rodolfo Álvarez-Sala

    Research Article 11 April 2013 Pages: 577 - 583

    

16. Cooperation between community pharmacists and general practitioners in eastern Germany: attitudes and needs

    • Anna-Franziska Wüstmann
    • Carsten Haase-Strey
    • Christoph Alexander Ritter

    Research Article 11 April 2013 Pages: 584 - 592

    

17. The use of a low dose hydrocortisone to prevent pulmonary embolism in patients with multiple trauma

    • Anis Chaari
    • Hatem Ghadhoune
    • Mounir Bouaziz

    Research Article 21 April 2013 Pages: 593 - 599

    

18. Medication reconciliation to solve discrepancies in discharge documents after discharge from the hospital

    • Marlies M. E. Geurts
    • Merel van der Flier
    • Johan J. de Gier

    Research Article 18 April 2013 Pages: 600 - 607

    

19. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand

    • Somsak Tiamkao
    • Jukrapope Jitpimolmard
    • Suthipun Jitpimolmard

    Research Article 07 May 2013 Pages: 608 - 612

    

20. Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study

    • Svetla Gadzhanova
    • Jenni Ilomäki
    • Elizabeth E. Roughead

    Research Article 16 May 2013 Pages: 613 - 620

    

21. CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention

    • Melissa Mejin
    • Wen Ni Tiong
    • Alan Yean Yip Fong

    Research Article 10 May 2013 Pages: 621 - 628

    

22. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis

    • Pauline Siew Mei Lai
    • Siew Siang Chua
    • Siew Pheng Chan

    Research Article 16 May 2013 Pages: 629 - 637

    

23. Profile of prescribing errors detected by clinical pharmacists in paediatric hospitals in Spain

    • Cecilia M. Fernández-Llamazares
    • Maite Pozas
    • Concha Álvarez-del-Vayo

    Research Article 25 May 2013 Pages: 638 - 646

    

24. Assessment of pharmacist’s recommendation of non-prescription medicines in Brazil: a simulated patient study

    • Alessandra Rezende Mesquita
    • Dalmare Anderson Bezerra de Oliveira Sá
    • Divaldo Pereira Lyra Jr.

    Research Article 06 June 2013 Pages: 647 - 655

25. Communication between community and hospital pharmacists: impact on medication reconciliation at admission

    • Xavier Pourrat
    • Hélène Corneau
    • Jacqueline Grassin

    Research Article 18 May 2013 Pages: 656 - 663